BioCare enjoys brisk sales
Najihah S | 30 Jun 2017 00:30
THE pharmaceutical industry is not showing signs of slowing down. In Malaysia alone, the revenue from the industry is worth RM12 bil annually. The positive development of the industry benefited many companies in the SME category.

For example, BioCare Group Sdn Bhd, which is a producer of respiratory problem solutions, has been enjoying growing demand for its metered dose inhaler (MDI).  

Founded by Kedah-born, Saravanan Govindasamy, the company morphed from being a supplier of generic pharmaceutical items to go into product development.

“While I was working for a pharmaceutical company, I had to deal with hospitals to bring in imported MDI items. The MDI product is used as a lifesaving drug for asthma patients. That was how I know that the demand for that particular product was much needed in the country,” Saravanan, who is its group managing director, tells FocusM.

Download and read the latest issue of Focus Malaysia here:
Shopee wraps up a record-breaking 2018

Shopee wraps up a record-breaking 2018 with over 12 million orders on 12.12 Birthday Sale

Impiana KLCC recognised for excellence at the HAPA

Impiana KLCC hotel recognised for excellence of its recreational spa and restaurant at the HAPA Malaysia Awards Series